Steven H. Holtzman

Filings by Steven H. Holtzman span 2 companies, the busiest being Biogen Inc. and Camp4 Therapeutics Corp. In total, 3 filings cover trades dated from 8 February 2016 to 15 October 2024.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 15 October 2024, the filings show a transaction in Camp4 Therapeutics Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.